Diagnamed Holdings Corp. (CSE:DMED)

Canada flag Canada · Delayed Price · Currency is CAD
0.0950
-0.0050 (-5.00%)
Jan 20, 2026, 3:59 PM EST
216.67%
Market Cap11.43M
Revenue (ttm)n/a
Net Income (ttm)-1.13M
Shares Out114.27M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume192,610
Average Volume665,500
Open0.1000
Previous Close0.1000
Day's Range0.0950 - 0.1000
52-Week Range0.0200 - 0.1400
Beta-1.15
RSI59.94
Earnings DateJan 30, 2026

About Diagnamed Holdings

Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdi... [Read more]

Sector Healthcare
CEO John Karagiannidis
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol DMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.